Blog

- Andrew Celentano

Implantica receives FDA approval for RefluxStop® – Opening the U.S. market

VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for RefluxStop®, the company’s implant-based treatment for gastroesophageal reflux disease (GERD). The approval allows Implantica to begin commercial launch activities in the United States, the world’s largest medical device market.

Read More »

AI-calculated brain age predicts dementia risk years before doctors can see it

Memory clinics still rely on visual rating scales to assess brain atrophy, yet these tools lack the sensitivity to catch subtle changes associated with early dementia. A measure of how old a person’s brain appears on brain scans compared with their actual age might be a potential predictor of who is more likely to develop dementia over the years, reports a new study published in Neurology.

Read More »

Simple mouth rinse may help detect stomach and colorectal cancer signals

It’s widely understood that the microbiome—especially microbes found in the mouth and the gut—can have a profound effect on health. In a study published in the journal Cell Host & Microbe on Aug. 20, researchers report that by analyzing the makeup of oral microbes, they may be able to detect signals associated with gastric (stomach) and colorectal cancer. These findings could lead to the development of new, less invasive screening tests for gastrointestinal cancers.

Read More »